Shaw Strategic Capital (SSC), is a family office that brings several decades of experience in investing in life sciences and helping companies scale toward liquidity events, including IPOs. SSC invest
...
SAB Biotherapeutics is a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing fully-human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or prog
...
Syncromune, Inc. is developing a platform immunotherapy technology to treat metastatic solid tumor cancers, with its lead program demonstrating powerful clinical results in mCRPC patients with planned
...
A statewide, not-for-profit, public/private life sciences industry association and economic development organization formed to actively promote, convene, build, advance, and grow South Carolina's life
...
Sutters.ai maximizes therapeutic value by repackaging stalled clinical candidates and proven commercial drugs into targeted nanocarriers. By solving delivery-driven efficacy and toxicity, we ensure th
...
)
)
)
)
){kind=logo}
){kind=logo}
